Newsletter | December 19, 2025

12.19.25 -- STREAM Edition: How Digital Tools Are Accelerating Biopharma Development

A Standardized Playbook For Gene Therapy Manufacturing

Video | Thermo Fisher Scientific Bioproduction

In this segment, Dr. Peter Marks shares developments in CMC for advanced therapies in the near future.

 

Value-Based Contracts With Tolga Tanguler

Video | Life Science Leader

In this chapter of Business of Biotech, Alnylam Chief Commercial Officer Tolga Tanguler addresses challenges and opportunities in the RNAi therapeutics commercialization effort. Catch the full episode here!

Building Better BioTherapeutics Using ML And Synthetic Biology

Webinar | ATUM

Explore ATUM's history with Machine Learning (ML) in Bio, as well as how they go about variable selection, searching the SQL space to find promoters, and finding antibodies.

A Data-Driven Approach To Container Closure Integrity

Webinar | West Pharmaceutical Services, Inc.

Gain confidence in your container closure system selection by utilizing a stepwise and data-driven approach to predicting and verifying container closure integrity.

How Digital Tools Are Accelerating Biopharma Development

Virtual Event | Bioprocess Online

This panel discussion features AbbVie's head of biologics purification development and digitization teams, Moiz Diwan, Ph.D., and independent technology consultant Kat Kozyrytska, who explore how companies like AbbVie are integrating automation, digitization, and modeling to improve process performance, achieve greater production scale, and progress towards the use of true digital twins in product development.

Investing In Innovation: Where Will The Next Breakthroughs Come From?

Video | Ecolab Life Sciences

In this video, Ecolab Life Sciences’ Jennifer Sorrells discusses bold strategic bioprocessing investment focusing on integrated digital platforms, flexible manufacturing, talent, and strategic partnerships. Sorrells also covers digital transformation's role in real-time process intelligence, maintaining quality during rapid scaling, and the future of autonomous manufacturing.